NovaBridge Biosciences
NBPLatest QuantConomy context for NBP: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Asset class
asset
Primary venue
—
Recent signals
0
SEC filings
18
Asset profile
NovaBridge Biosciences
QuantConomy has a structured record for NBP. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- NBP
- Name
- NovaBridge Biosciences
- Coverage
- 0 market/data records
Latest signal rows
Recent signals for NBP
Scored rows are pulled from the same signal API used by the digests.
No recent scored signal rows were returned for NBP.
Recent insider transactions
Buys, last 90d
1
Sells, last 90d
1
Rows
18
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jul 8, 2026 | Hagler Mark Arnold | Chief Commercial Officer | grant | 949,050 | — | — | 4 on EDGAR |
| Jul 8, 2026 | Lin Liwei Lorraine | General Counsel | grant | 254,780 | — | — | 4 on EDGAR |
| Jul 6, 2026 | Gupta Srishti | Chief Executive Officer | grant | 3,000,000 | — | — | 4 on EDGAR |
| Jul 4, 2026 | Xu Cong Claire | SVP, Clinical Development | exercise | 12,432 | — | — | 4 on EDGAR |
| Jun 29, 2026 | Fu Wei | Director | grant | 725,140 | — | — | 4 on EDGAR |
| Jun 22, 2026 | Cao Sean Wuxiong | Chief Bus. Development Officer | grant | 181,280 | — | — | 4 on EDGAR |
| Jun 17, 2026 | Dennis Phillip Andrew | Chief Medical Officer | exercise | 23,695 | — | — | 4 on EDGAR |
| May 30, 2026 | Xu Cong Claire | SVP, Clinical Development | exercise | 9,382 | — | — | 4 on EDGAR |
| May 14, 2026 | Cao Sean Wuxiong | See Remarks | sale | 21,399 | $1.99 | $42,584 | 4 on EDGAR |
| Apr 24, 2026 | Hagler Mark Arnold | See Remarks | purchase | 230,000 | $2.51 | $577,300 | 4 on EDGAR |
| — | Zhang Xiaofan Neo | Chief Investment Officer | — | — | — | — | 3 on EDGAR |
| — | Xu Cong Claire | See Remarks | — | — | — | — | 3 on EDGAR |
| — | Cao Sean Wuxiong | See Remarks | — | — | — | — | 3 on EDGAR |
| — | Fu Wei | Director | — | — | — | — | 3 on EDGAR |
| — | Wu Joanna Xuqiong | See Remarks | — | — | — | — | 3 on EDGAR |
| — | Fu Xi-Yong | See Remarks | — | — | — | — | 3 on EDGAR |
| — | Xu Cong Claire | See remarks | — | — | — | — | 3 on EDGAR |
| — | Dennis Phillip Andrew | Chief Medical Officer | — | — | — | — | 3 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Get the data
Query NBP context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access